SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-018914
Filing Date
2022-05-19
Accepted
2022-05-19 18:01:41
Documents
1
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 21452
  Complete submission text file 0000899243-22-018914.txt   24649
Mailing Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022 212-883-0200
RP Management, LLC (Reporting) CIK: 0001507673 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 22944628

Mailing Address 110 E 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address
Legorreta Pablo G. (Reporting) CIK: 0001507678 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 22944629

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address 110 EAST 59TH STREET SUITE 3300 NEW YORK NY 10022 212-883-0200
RPI Finance Trust (Reporting) CIK: 0001793690 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 22944627

Mailing Address C/O RP MANAGEMENT, LLC 100 E. 59TH ST., 33RD FLOOR NEW YORK NY 10022
Business Address C/O RP MANAGEMENT, LLC 100 E. 59TH ST., 33RD FLOOR NEW YORK NY 10022 212-883-0200
Royalty Pharma Investments 2019 ICAV (Reporting) CIK: 0001909645 (see all company filings)

State of Incorp.: L2 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 22944626